Avanos Medical Valuation
| 8HH Stock | 13.10 0.10 0.76% |
At this time, the firm appears to be undervalued. Avanos Medical shows a prevailing Real Value of USD13.95 per share. The current price of the firm is USD13.1. Our model approximates the value of Avanos Medical from analyzing the firm fundamentals such as price to sales of 1.60 X, and Current Valuation of 1.35 B as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Avanos Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Avanos Medical is based on 3 months time horizon. Increasing Avanos Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Avanos Medical's intrinsic value may or may not be the same as its current market price of 13.10, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.1 | Real 13.95 | Hype 13.1 | Naive 13.28 |
The intrinsic value of Avanos Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avanos Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avanos Medical helps investors to forecast how Avanos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avanos Medical more accurately as focusing exclusively on Avanos Medical's fundamentals will not take into account other important factors: Avanos Medical Total Value Analysis
Avanos Medical is presently anticipated to have takeover price of 1.35 B with market capitalization of 1.26 B, debt of 226.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Avanos Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.35 B | 1.26 B | 226.3 M |
Avanos Medical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Avanos implies not a very effective usage of assets in March.Avanos Medical Profitability Analysis
The company reported the revenue of 820 M. Net Income was 50.5 M with profit before overhead, payroll, taxes, and interest of 0.About Avanos Medical Valuation
The stock valuation mechanism determines Avanos Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Avanos Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avanos Medical. We calculate exposure to Avanos Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avanos Medical's related companies.8 Steps to conduct Avanos Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avanos Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avanos Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Avanos Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Avanos Medical's revenue streams: Identify Avanos Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Avanos Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Avanos Medical's growth potential: Evaluate Avanos Medical's management, business model, and growth potential.
- Determine Avanos Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avanos Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.